共查询到20条相似文献,搜索用时 14 毫秒
1.
![]() |
|||||||
|
|||||||
共查询到20条相似文献,搜索用时 14 毫秒
1.
Objective:National dosimetry audits are a fundamental part of quality assurance in radiotherapy, especially for new techniques. Intraoperative radiotherapy with a compact mobile kilovoltage X-ray source is a novel approach for the treatment of breast and other cancers. All seven current clinical sites in the UK were audited by a single visiting group and set of measurement equipment.Methods:Measurements of output, isotropy and depth doses were performed using an ion chamber in solid water, thermoluminescent dosemeters and radiochromic film, respectively.Results:The mean difference between measured and planned dose across all centres was −3.2±2.7%. Measured isotropy was within ±3% around the lateral plane of the X-ray source and +11±4% in the forward direction compared with the lateral plane. Measured depth doses were agreed within 5±2% of manufacturer-provided calibration values or a mean gamma index of 97% at a tolerance of 7%/0.5 mm.Conclusion:Agreement within measurement uncertainties was found for all three parameters except forward anisotropy, which is unlikely to be clinically significant. Steep dose gradients increase the sensitivity to small variations in positioning, but these tests are practical for use in interdepartmental audits and local baseline comparison.Advances in knowledge:The first UK interdepartmental audit of intraoperative radiotherapy builds confidence in the delivery of this treatment.Dosimetry audits have been a fundamental part of quality assurance (QA) in UK radiotherapy departments for over 20 years [1–6]. More recently, ongoing verification of established systems has been delegated to regional audit groups; however, new techniques such as intensity-modulated radiotherapy [7,8] or volumetric modulated arc therapy [9] have been assessed on a national level. This gives confidence in the accurate, safe and consistent delivery of complex treatments, regardless of location or prior experience.Intraoperative radiotherapy (IORT) has also been practised in the UK for nearly 20 years, using a compact mobile 50 kV X-ray device called PRS400 (Photoelectron Corporation, Lexington, MA) and, more recently, INTRABEAM® (PRS500; Carl Zeiss Surgical, Oberkochen, Germany). Initially, the system was used for intracranial stereotaxy [10] but found wider application in the delivery of a single fraction of radiation soon after surgical excision of breast tumours [11]. Most patients have been treated as part of the targeted intraoperative radiotherapy (TARGIT) international randomised controlled trial [12], although some other cases have also been successfully treated where external beam therapy was contraindicated [13]. Full calibration of the system is provided by the manufacturer, but recently, methods for independent dosimetry and quality assurance have been described [14,15]. The aim of this study was to audit all UK clinical centres in 2012 (Ninewells, Dundee, UK | Guy''s and St Thomas'', London, UK | North Middlesex, London, UK | Princess Grace, London, UK | Royal Free, London, UK (visiting centre) | St John and St Elizabeth, London, UK | Royal Hampshire County, Winchester, UK | |
设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |